On September 1st, 2021, Felda Yeung spoke on a panel alongside Davin Teo, Managing Director of Alvarez & Marsal’s Disputes & Investigations Practice in Hong Kong, about employee misconduct and internal investigations at the workplace. Employee misconduct can take many forms, but whether this involves fraud, corruption, data/IP theft or harassment, planning and implementing the
Evelyn Chan and Yandy Lam Contribute Hong Kong Chapter on Enforcement of Judgements for Lexology
Evelyn Chan and Yandy Lam have contributed the Hong Kong Chapter for Lexology’s Enforcement of Judgements 2022. Representing jurisdictions worldwide, this new volume in the Getting The Deal Through series offers expert analysis of the key issues relating to the enforcement of foreign judgments. Topics covered include: treaties, regulations and conventions, limitation periods, types of enforceable order, competent
A new chapter in cross-border insolvency: the first application by Hong Kong liquidators for recognition and assistance in Mainland China
Table of Contents The Procedure The Law Conclusion On 14 May 2021, a cooperation mechanism was established between the Mainland and Hong Kong in the form of the Record of Meeting of the Supreme People’s Court and the Government of the Hong Kong Special Administrative Region and Mutual Recognition of and Assistance to Bankruptcy (Insolvency)
Chris Wong Speaks on Panel at TechLaw. Fest 2021
Executive Partner Chris Wong will speak on a panel on AML/CFT Regulatory Compliance and Risk Management by Law Firms in the Digital Age at TechLaw.Fest 2021’s event on 22nd September 2021. The panel will explore the issues faced by law firms in managing their AML/CFT risks and compliance obligations. Are there unique challenges associated with scale? Are current tools
Gall Obtains Proprietary Injunction over Shares in Lunan Pharmaceutical Group Corporation
Gall recently obtained a proprietary injunction in Hong Kong for its clients, Ms Zhao Long and a British Virgin Islands (“BVI”) company Endushantum Investments Co., Ltd. (“Endushantum”) in a complex cross-border dispute involving the shareholdings in Lunan Pharmaceutical Group Corporation (“Lunan”), a significant PRC pharmaceutical company, and other group companies (collectively, the “PRC Shares”). On